Medicine and Dentistry
Hip
100%
Total Knee Arthroplasty
97%
Knee Arthroplasty
91%
Venous Thromboembolism
85%
Total Hip Arthroplasty
69%
Cohort Analysis
58%
Arthroplasty
48%
Hip Arthroplasty
48%
COVID-19
42%
Shoulder Arthroplasty
42%
Cardiovascular Disease
42%
Socioeconomic Status
42%
Spastic Diplegia
42%
Cardiovascular System
42%
Clinical Prediction Model
42%
Periprosthetic Joint Infection
42%
Prevalence
42%
Case-Control Study
42%
Inflammatory Bowel Disease
42%
Appendectomy
42%
Colorectal Tumor
42%
Major Bleeding
42%
Direct Oral Anticoagulant
42%
Quality Adjusted Life Year
35%
Drug Therapy
29%
Cumulative Incidence
28%
Healthcare Associated Infection
27%
Thromboprophylaxis
21%
Atrial Fibrillation
16%
Ulcerative Colitis
15%
Revision Arthroplasty
14%
Patient Characteristics
14%
Chronic Lung Disease
10%
Chronic Kidney Disease
10%
Infection
10%
Knee
10%
Population
9%
Patient with Inflammatory Bowel Disease
9%
Patient Registry
8%
Epileptic Seizure
7%
Osteoarthritis
7%
Age Distribution
7%
Sex Ratio
7%
Anesthesiologist
7%
Patient History of Surgery
5%
General Practitioner
5%
Cohabitation
5%
Linear Regression Analysis
5%
Logistic Regression Analysis
5%
Asthma
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Disease
85%
Ischemic Heart Disease
52%
Pandemic
42%
Cerebral Palsy
42%
Prevalence
42%
Obesity
42%
Case-Control Study
42%
Venous Thromboembolism
42%
Direct Oral Anticoagulant
42%
Bleeding
42%
Comorbidity
30%
Osteoarthritis
21%
Atrial Fibrillation
20%
Cohort Study
20%
Heart Failure
19%
Limb Malformation
14%
Ethanol
10%
Infection
10%
Chronic Kidney Failure
10%
Chronic Lung Disease
10%
Heart Arrhythmia
9%
Heart Disease
9%
Diabetes Mellitus
8%
Stable Angina Pectoris
8%
Non ST Segment Elevation Myocardial Infarction
8%
Disease
5%
Anticoagulant Agent
5%
Randomized Controlled Trial
5%
Keyphrases
Total Knee Arthroplasty
42%
Venous Thromboembolism
42%
Major Bleeding
42%
Direct Oral Anticoagulants
42%
Therapeutic Agents
42%
Total Hip
42%
Thromboprophylaxis
18%
Atrial Fibrillation
18%
Confidence Interval
18%
Cumulative Incidence
18%
Clinical High Risk
12%
Arthroplasty Patients
12%
Randomized Controlled Trial
6%
Surgical Site
6%
Denmark
6%
Competing Risks
6%
Anticoagulant Medications
6%
Reported Incidence
6%
Registry-based
6%
Venous Thromboembolism Risk
6%
Bleeding Events
6%
Postoperative Venous Thromboembolism
6%